UNSPSC 51431610: Fendiline hydrochloride

This classification denotes a calcium channel blocker with the molecular formula C23H25N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HEM3Z10IIK, chemically known as n-(3,3-diphenylpropyl)-alpha-methylbenzylamine hydrochloride but more generally known as fendiline hydrochloride, which bears US NIH Compound Identifier 26154. European Medicines Agency schedules Fendiline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02113MIG.

Most nations, for tariff and trade purposes, schedule fendiline hydrochloride under HS 29214980 and SITC 51454. As of Q4 2014, FENDILINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C1CCCCC1)NCCC(C2CCCCC2)C3CCCCC3.CL.

UNSPSC 51431610 Fendiline hydrochloride is a Commodity code that in practice captures emergency medical pharmaceuticals and related advanced life support medications procured by municipal fire and rescue services. State and local governments use this code to source specific injectable medications required for pre-hospital emergency care — epinephrine, labetalol, adenosine, diltiazem, and other cardiac and respiratory agents — in bulk quantities for Fire-EMS deployment. Issuing bodies soliciting under the code are primarily municipal fire departments and rescue services operating through city purchasing offices. The scope includes firm pricing on unit quantities, expiration-date guarantees (typically nine months or longer from acceptance), rapid delivery windows (ten calendar days or less), and replacement or pickup provisions for expired stock before the contracted expiration period expires. Vendors must supply Safety Data Sheets compliant with OSHA Hazard Communication Standards and often must meet accessibility documentation requirements including VPAT and Section 508 conformance.

The code shows recent activity in Florida. The City of Tampa's Purchasing Department posted an IFB (Bid No. 26-P-00188) for Advanced Life Support Medications on April 24, 2026, with a response deadline of April 8, 2026 — a date that has passed — for Tampa Fire Rescue. The solicitation requested 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials. The estimated contract value was $40,000, with a one-year initial term and options to renew for two additional one-year periods plus three unilateral 30-day extensions. The City offered a five-percent Small Local Business Enterprise sheltered-market discount (not to exceed $10,000) and required SLBE participation documentation including DMI-20 and DMI-40 forms within ten workdays of award notice.